
Favirab1000 IU/5
Synovia Pharma PLC
Established / Guideline-Supported Use Rabies Immune Globulin is indicated, together with rabies vaccine and more.
Rabies Immune Globulin is indicated, together with rabies vaccine, for post-exposure prophylaxis (PEP) of rabies in persons who have not previously completed a full pre-exposure or post-exposure rabies vaccination series and who have been bitten, scratched, or otherwise exposed (e.g. mucous membrane or open wound contact with saliva) to an animal suspected or confirmed to be rabid, per WHO and CDC/ACIP guidance.
Rabies Immune Globulin is not given to persons with a reliably documented history of complete pre-exposure or post-exposure rabies vaccination (they receive booster vaccine doses only), and it has no role once the active antibody response to the vaccine series is already under way (see Precautions).
| Product type | Dose |
|---|---|
| Human Rabies Immune Globulin (HRIG) | 20 IU/kg body weight, given once |
| Equine/Purified Equine Rabies Immune Globulin (ERIG) | 40 IU/kg body weight, given once |
The full calculated dose of Rabies Immune Globulin should be infiltrated as thoroughly as anatomically possible into and around all wound sites. If the calculated dose exceeds what can be infiltrated locally (e.g. small digits/nose), any remaining volume is given by intramuscular injection at a site distant from the wound. Rabies Immune Globulin must be given at a different anatomical site (e.g. opposite limb) from the concurrently administered rabies vaccine, using a separate syringe and needle, and must never be mixed in the same syringe as the vaccine. Thorough wound washing with soap and water for several minutes is an essential concurrent step and does not replace Rabies Immune Globulin administration.
Rabies Immune Globulin should be given as early as possible after exposure, ideally with the first dose of rabies vaccine (Day 0). See Precautions for the timing cut-off after vaccination has begun.
Common: local pain, tenderness, erythema, or swelling at the infiltration/injection site; low-grade fever; mild headache; myalgia.
Uncommon/rare: urticaria, angioedema; rarely, serum sickness-type reactions (more often with equine-derived Rabies Immune Globulin); rare reports of nephrotic syndrome; anaphylaxis (rare, but can be serious — see Contraindications and Precautions for monitoring advice).
A documented history of a severe (anaphylactic) hypersensitivity reaction to Rabies Immune Globulin itself, or, for equine-derived products, a known severe hypersensitivity to horse serum/equine proteins, is a contraindication.
However, because rabies is almost universally fatal once clinical symptoms appear, a history of hypersensitivity does not remove the need for Rabies Immune Globulin in a genuine high-risk rabies exposure; in that situation it should still be given, under close medical supervision with premedication and resuscitation facilities available, per clinical judgment.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.